nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—Corticosteroid Hormone Receptor Agonists—Prednisone—Crohn's disease	0.253	1	CiPCiCtD
Dexamethasone—Prednisone—Crohn's disease	0.176	1	CrCtD
Dexamethasone—psoriatic arthritis—Crohn's disease	0.0887	0.387	CtDrD
Dexamethasone—ankylosing spondylitis—Crohn's disease	0.0731	0.319	CtDrD
Dexamethasone—ulcerative colitis—Crohn's disease	0.0672	0.294	CtDrD
Dexamethasone—PLA2G1B—Sulfasalazine—Crohn's disease	0.0611	0.483	CbGbCtD
Dexamethasone—PTGS2—Crohn's disease	0.0324	1	CbGaD
Dexamethasone—PTGS2—Balsalazide—Crohn's disease	0.0142	0.112	CbGbCtD
Dexamethasone—PTGS2—Mesalazine—Crohn's disease	0.0113	0.0897	CbGbCtD
Dexamethasone—NR3C1—Prednisone—Crohn's disease	0.00717	0.0567	CbGbCtD
Dexamethasone—ABCC2—Sulfasalazine—Crohn's disease	0.00641	0.0507	CbGbCtD
Dexamethasone—PTGS2—Sulfasalazine—Crohn's disease	0.00633	0.0501	CbGbCtD
Dexamethasone—SLCO1A2—Prednisone—Crohn's disease	0.00618	0.0489	CbGbCtD
Dexamethasone—Testolactone—Prednisone—Crohn's disease	0.00612	0.05	CrCrCtD
Dexamethasone—Prednicarbate—Prednisone—Crohn's disease	0.00612	0.05	CrCrCtD
Dexamethasone—Fluocortolone—Prednisone—Crohn's disease	0.00594	0.0486	CrCrCtD
Dexamethasone—ABCG2—Sulfasalazine—Crohn's disease	0.00579	0.0458	CbGbCtD
Dexamethasone—Alclometasone—Prednisone—Crohn's disease	0.00578	0.0472	CrCrCtD
Dexamethasone—Amcinonide—Prednisone—Crohn's disease	0.00562	0.0459	CrCrCtD
Dexamethasone—Budesonide—Prednisone—Crohn's disease	0.00562	0.0459	CrCrCtD
Dexamethasone—Fludrocortisone—Prednisone—Crohn's disease	0.00548	0.0448	CrCrCtD
Dexamethasone—Diflorasone—Prednisone—Crohn's disease	0.00548	0.0448	CrCrCtD
Dexamethasone—Clobetasol propionate—Prednisone—Crohn's disease	0.00548	0.0448	CrCrCtD
Dexamethasone—Desonide—Prednisone—Crohn's disease	0.00548	0.0448	CrCrCtD
Dexamethasone—Flunisolide—Prednisone—Crohn's disease	0.00548	0.0448	CrCrCtD
Dexamethasone—Paramethasone—Prednisone—Crohn's disease	0.00534	0.0436	CrCrCtD
Dexamethasone—Desoximetasone—Prednisone—Crohn's disease	0.00521	0.0426	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Prednisone—Crohn's disease	0.00509	0.0416	CrCrCtD
Dexamethasone—Fluorometholone—Prednisone—Crohn's disease	0.00509	0.0416	CrCrCtD
Dexamethasone—Loteprednol—Prednisone—Crohn's disease	0.00509	0.0416	CrCrCtD
Dexamethasone—Mometasone—Prednisone—Crohn's disease	0.00509	0.0416	CrCrCtD
Dexamethasone—Triamcinolone—Prednisone—Crohn's disease	0.00509	0.0416	CrCrCtD
Dexamethasone—Rimexolone—Prednisone—Crohn's disease	0.00497	0.0406	CrCrCtD
Dexamethasone—Betamethasone—Prednisone—Crohn's disease	0.00497	0.0406	CrCrCtD
Dexamethasone—Methylprednisolone—Prednisone—Crohn's disease	0.00475	0.0389	CrCrCtD
Dexamethasone—Prednisolone—Prednisone—Crohn's disease	0.00465	0.038	CrCrCtD
Dexamethasone—Hydrocortisone—Prednisone—Crohn's disease	0.00447	0.0365	CrCrCtD
Dexamethasone—CYP3A5—Sulfasalazine—Crohn's disease	0.00321	0.0254	CbGbCtD
Dexamethasone—CYP2C19—Prednisone—Crohn's disease	0.00207	0.0164	CbGbCtD
Dexamethasone—ABCB11—bile—Crohn's disease	0.0017	0.158	CbGeAlD
Dexamethasone—ABCB1—Prednisone—Crohn's disease	0.00167	0.0132	CbGbCtD
Dexamethasone—CYP3A4—Prednisone—Crohn's disease	0.001	0.00792	CbGbCtD
Dexamethasone—ABCC2—bile—Crohn's disease	0.000865	0.0802	CbGeAlD
Dexamethasone—PLA2G1B—mouth—Crohn's disease	0.00054	0.0501	CbGeAlD
Dexamethasone—ANXA1—gall bladder—Crohn's disease	0.000464	0.043	CbGeAlD
Dexamethasone—ANXA1—mouth—Crohn's disease	0.000413	0.0383	CbGeAlD
Dexamethasone—PLA2G1B—epithelium—Crohn's disease	0.000314	0.0291	CbGeAlD
Dexamethasone—CYP4A11—digestive system—Crohn's disease	0.000288	0.0267	CbGeAlD
Dexamethasone—ANXA1—epithelium—Crohn's disease	0.00024	0.0223	CbGeAlD
Dexamethasone—PLA2G1B—digestive system—Crohn's disease	0.000239	0.0222	CbGeAlD
Dexamethasone—ANXA1—smooth muscle tissue—Crohn's disease	0.000231	0.0215	CbGeAlD
Dexamethasone—ANXA1—skin of body—Crohn's disease	0.000228	0.0212	CbGeAlD
Dexamethasone—Pancreatitis acute—Mesalazine—Crohn's disease	0.000226	0.00687	CcSEcCtD
Dexamethasone—Acneiform eruption—Prednisone—Crohn's disease	0.000219	0.00665	CcSEcCtD
Dexamethasone—Cognitive impairment—Prednisone—Crohn's disease	0.000212	0.00643	CcSEcCtD
Dexamethasone—Cataract subcapsular—Prednisone—Crohn's disease	0.000212	0.00643	CcSEcCtD
Dexamethasone—ANXA1—mammalian vulva—Crohn's disease	0.000208	0.0193	CbGeAlD
Dexamethasone—Glucose tolerance impaired—Prednisone—Crohn's disease	0.000205	0.00623	CcSEcCtD
Dexamethasone—Ulcer—Mercaptopurine—Crohn's disease	0.000204	0.00618	CcSEcCtD
Dexamethasone—Drug dependence—Prednisone—Crohn's disease	0.000199	0.00605	CcSEcCtD
Dexamethasone—Benign intracranial hypertension—Prednisone—Crohn's disease	0.000188	0.00571	CcSEcCtD
Dexamethasone—ABCB11—digestive system—Crohn's disease	0.000186	0.0172	CbGeAlD
Dexamethasone—ANXA1—lymphoid tissue—Crohn's disease	0.000185	0.0172	CbGeAlD
Dexamethasone—Skin atrophy—Prednisone—Crohn's disease	0.000183	0.00556	CcSEcCtD
Dexamethasone—ANXA1—digestive system—Crohn's disease	0.000183	0.0169	CbGeAlD
Dexamethasone—Hirsutism—Mesalazine—Crohn's disease	0.00018	0.00546	CcSEcCtD
Dexamethasone—Thromboembolism—Prednisone—Crohn's disease	0.000174	0.00528	CcSEcCtD
Dexamethasone—Skin striae—Prednisone—Crohn's disease	0.000174	0.00528	CcSEcCtD
Dexamethasone—Papilloedema—Prednisone—Crohn's disease	0.000174	0.00528	CcSEcCtD
Dexamethasone—Atrophy—Prednisone—Crohn's disease	0.00017	0.00515	CcSEcCtD
Dexamethasone—Dermatitis acneiform—Prednisone—Crohn's disease	0.000162	0.00491	CcSEcCtD
Dexamethasone—Cardiomegaly—Prednisone—Crohn's disease	0.000152	0.0046	CcSEcCtD
Dexamethasone—Oesophageal ulcer—Prednisone—Crohn's disease	0.000152	0.0046	CcSEcCtD
Dexamethasone—NR3C2—smooth muscle tissue—Crohn's disease	0.00015	0.0139	CbGeAlD
Dexamethasone—Osteonecrosis—Prednisone—Crohn's disease	0.000149	0.00451	CcSEcCtD
Dexamethasone—CYP1A1—mouth—Crohn's disease	0.000148	0.0137	CbGeAlD
Dexamethasone—Hypertrichosis—Prednisone—Crohn's disease	0.000146	0.00442	CcSEcCtD
Dexamethasone—Epilepsy—Prednisone—Crohn's disease	0.000146	0.00442	CcSEcCtD
Dexamethasone—Blister—Mesalazine—Crohn's disease	0.000145	0.0044	CcSEcCtD
Dexamethasone—PGR—epithelium—Crohn's disease	0.000145	0.0134	CbGeAlD
Dexamethasone—Meningitis—Prednisone—Crohn's disease	0.000143	0.00433	CcSEcCtD
Dexamethasone—PTGS2—gall bladder—Crohn's disease	0.00014	0.0129	CbGeAlD
Dexamethasone—PGR—smooth muscle tissue—Crohn's disease	0.000139	0.0129	CbGeAlD
Dexamethasone—Opportunistic infection—Prednisone—Crohn's disease	0.000137	0.00417	CcSEcCtD
Dexamethasone—Rash erythematous—Mesalazine—Crohn's disease	0.000137	0.00414	CcSEcCtD
Dexamethasone—NR3C2—mammalian vulva—Crohn's disease	0.000135	0.0125	CbGeAlD
Dexamethasone—Withdrawal symptom—Prednisone—Crohn's disease	0.000135	0.00409	CcSEcCtD
Dexamethasone—Intracranial pressure increased—Prednisone—Crohn's disease	0.000132	0.00402	CcSEcCtD
Dexamethasone—Leukoderma—Prednisone—Crohn's disease	0.00013	0.00395	CcSEcCtD
Dexamethasone—Cognitive disorder—Prednisone—Crohn's disease	0.000128	0.00388	CcSEcCtD
Dexamethasone—Impaired healing—Prednisone—Crohn's disease	0.000128	0.00388	CcSEcCtD
Dexamethasone—Intraocular pressure increased—Prednisone—Crohn's disease	0.000126	0.00382	CcSEcCtD
Dexamethasone—Acne—Mesalazine—Crohn's disease	0.000124	0.00377	CcSEcCtD
Dexamethasone—PTGS2—mouth—Crohn's disease	0.000124	0.0115	CbGeAlD
Dexamethasone—Pancreatitis acute—Prednisone—Crohn's disease	0.00012	0.00364	CcSEcCtD
Dexamethasone—Amenorrhoea—Mesalazine—Crohn's disease	0.000119	0.00361	CcSEcCtD
Dexamethasone—NR3C2—digestive system—Crohn's disease	0.000118	0.011	CbGeAlD
Dexamethasone—Vasculitis—Azathioprine—Crohn's disease	0.000118	0.00357	CcSEcCtD
Dexamethasone—CYP1B1—smooth muscle tissue—Crohn's disease	0.000117	0.0109	CbGeAlD
Dexamethasone—Endophthalmitis—Prednisone—Crohn's disease	0.000116	0.00353	CcSEcCtD
Dexamethasone—Trauma—Prednisone—Crohn's disease	0.000116	0.00353	CcSEcCtD
Dexamethasone—CYP1B1—skin of body—Crohn's disease	0.000116	0.0107	CbGeAlD
Dexamethasone—Arthropathy—Mesalazine—Crohn's disease	0.000115	0.00349	CcSEcCtD
Dexamethasone—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.000113	0.00342	CcSEcCtD
Dexamethasone—PGR—lymphoid tissue—Crohn's disease	0.000111	0.0103	CbGeAlD
Dexamethasone—Leukocytosis—Mesalazine—Crohn's disease	0.000111	0.00338	CcSEcCtD
Dexamethasone—Embolism venous—Prednisone—Crohn's disease	0.00011	0.00333	CcSEcCtD
Dexamethasone—Hypernatraemia—Prednisone—Crohn's disease	0.000105	0.00319	CcSEcCtD
Dexamethasone—ANXA1—lymph node—Crohn's disease	0.000104	0.00968	CbGeAlD
Dexamethasone—SLCO1A2—digestive system—Crohn's disease	0.000101	0.0094	CbGeAlD
Dexamethasone—Menstruation irregular—Prednisone—Crohn's disease	9.99e-05	0.00303	CcSEcCtD
Dexamethasone—Skin exfoliation—Mesalazine—Crohn's disease	9.98e-05	0.00303	CcSEcCtD
Dexamethasone—Osteoporosis—Prednisone—Crohn's disease	9.87e-05	0.00299	CcSEcCtD
Dexamethasone—Neuropathy—Mesalazine—Crohn's disease	9.82e-05	0.00298	CcSEcCtD
Dexamethasone—Dry eye—Mesalazine—Crohn's disease	9.66e-05	0.00293	CcSEcCtD
Dexamethasone—Multiple fractures—Prednisone—Crohn's disease	9.52e-05	0.00289	CcSEcCtD
Dexamethasone—Hirsutism—Prednisone—Crohn's disease	9.52e-05	0.00289	CcSEcCtD
Dexamethasone—Fracture—Prednisone—Crohn's disease	9.52e-05	0.00289	CcSEcCtD
Dexamethasone—Ecchymosis—Mesalazine—Crohn's disease	9.45e-05	0.00287	CcSEcCtD
Dexamethasone—ABCC2—digestive system—Crohn's disease	9.45e-05	0.00876	CbGeAlD
Dexamethasone—CYP1B1—lymphoid tissue—Crohn's disease	9.37e-05	0.00869	CbGeAlD
Dexamethasone—CYP17A1—lymph node—Crohn's disease	9.35e-05	0.00867	CbGeAlD
Dexamethasone—CYP1B1—digestive system—Crohn's disease	9.25e-05	0.00858	CbGeAlD
Dexamethasone—Optic neuritis—Prednisone—Crohn's disease	8.99e-05	0.00273	CcSEcCtD
Dexamethasone—CYP11A1—lymph node—Crohn's disease	8.7e-05	0.00807	CbGeAlD
Dexamethasone—Embolism—Prednisone—Crohn's disease	8.62e-05	0.00262	CcSEcCtD
Dexamethasone—CYP1A1—epithelium—Crohn's disease	8.6e-05	0.00797	CbGeAlD
Dexamethasone—Alopecia—Mercaptopurine—Crohn's disease	8.55e-05	0.00259	CcSEcCtD
Dexamethasone—Eye pain—Mesalazine—Crohn's disease	8.41e-05	0.00255	CcSEcCtD
Dexamethasone—NR3C1—epithelium—Crohn's disease	8.34e-05	0.00773	CbGeAlD
Dexamethasone—Peptic ulcer—Prednisone—Crohn's disease	8.28e-05	0.00251	CcSEcCtD
Dexamethasone—CYP1A1—skin of body—Crohn's disease	8.18e-05	0.00758	CbGeAlD
Dexamethasone—CYP2C19—digestive system—Crohn's disease	8.12e-05	0.00753	CbGeAlD
Dexamethasone—Increased appetite—Mesalazine—Crohn's disease	8.08e-05	0.00245	CcSEcCtD
Dexamethasone—NR3C1—smooth muscle tissue—Crohn's disease	8.04e-05	0.00745	CbGeAlD
Dexamethasone—CYP2B6—skin of body—Crohn's disease	7.95e-05	0.00737	CbGeAlD
Dexamethasone—Dermatitis bullous—Mesalazine—Crohn's disease	7.94e-05	0.00241	CcSEcCtD
Dexamethasone—NR3C1—skin of body—Crohn's disease	7.93e-05	0.00736	CbGeAlD
Dexamethasone—Myopathy—Prednisone—Crohn's disease	7.89e-05	0.00239	CcSEcCtD
Dexamethasone—Suicidal ideation—Prednisone—Crohn's disease	7.89e-05	0.00239	CcSEcCtD
Dexamethasone—ABCG2—mammalian vulva—Crohn's disease	7.86e-05	0.00728	CbGeAlD
Dexamethasone—Hepatomegaly—Prednisone—Crohn's disease	7.82e-05	0.00237	CcSEcCtD
Dexamethasone—Delusion—Prednisone—Crohn's disease	7.82e-05	0.00237	CcSEcCtD
Dexamethasone—Lethargy—Mesalazine—Crohn's disease	7.75e-05	0.00235	CcSEcCtD
Dexamethasone—Mania—Prednisone—Crohn's disease	7.61e-05	0.00231	CcSEcCtD
Dexamethasone—Osteoarthritis—Mesalazine—Crohn's disease	7.59e-05	0.0023	CcSEcCtD
Dexamethasone—Migraine—Mesalazine—Crohn's disease	7.47e-05	0.00227	CcSEcCtD
Dexamethasone—Affect lability—Mesalazine—Crohn's disease	7.47e-05	0.00227	CcSEcCtD
Dexamethasone—CYP1A1—mammalian vulva—Crohn's disease	7.46e-05	0.00691	CbGeAlD
Dexamethasone—Neuritis—Prednisone—Crohn's disease	7.41e-05	0.00225	CcSEcCtD
Dexamethasone—Glaucoma—Prednisone—Crohn's disease	7.35e-05	0.00223	CcSEcCtD
Dexamethasone—NR3C1—mammalian vulva—Crohn's disease	7.24e-05	0.00671	CbGeAlD
Dexamethasone—PTGS2—epithelium—Crohn's disease	7.22e-05	0.00669	CbGeAlD
Dexamethasone—Mood swings—Mesalazine—Crohn's disease	7.19e-05	0.00218	CcSEcCtD
Dexamethasone—Fungal infection—Prednisone—Crohn's disease	7.16e-05	0.00217	CcSEcCtD
Dexamethasone—Necrosis—Prednisone—Crohn's disease	7.05e-05	0.00214	CcSEcCtD
Dexamethasone—Abscess—Prednisone—Crohn's disease	6.99e-05	0.00212	CcSEcCtD
Dexamethasone—Dry skin—Mesalazine—Crohn's disease	6.96e-05	0.00211	CcSEcCtD
Dexamethasone—PTGS2—smooth muscle tissue—Crohn's disease	6.96e-05	0.00645	CbGeAlD
Dexamethasone—Oedema—Mercaptopurine—Crohn's disease	6.87e-05	0.00209	CcSEcCtD
Dexamethasone—PTGS2—skin of body—Crohn's disease	6.87e-05	0.00637	CbGeAlD
Dexamethasone—Glycosuria—Prednisone—Crohn's disease	6.83e-05	0.00207	CcSEcCtD
Dexamethasone—NR3C2—lymph node—Crohn's disease	6.76e-05	0.00627	CbGeAlD
Dexamethasone—Thrombocytopenia—Mercaptopurine—Crohn's disease	6.73e-05	0.00204	CcSEcCtD
Dexamethasone—Petechiae—Prednisone—Crohn's disease	6.72e-05	0.00204	CcSEcCtD
Dexamethasone—Acne—Prednisone—Crohn's disease	6.57e-05	0.002	CcSEcCtD
Dexamethasone—Anorexia—Mercaptopurine—Crohn's disease	6.55e-05	0.00199	CcSEcCtD
Dexamethasone—CYP1A1—digestive system—Crohn's disease	6.54e-05	0.00606	CbGeAlD
Dexamethasone—CYP2B6—lymphoid tissue—Crohn's disease	6.43e-05	0.00597	CbGeAlD
Dexamethasone—NR3C1—lymphoid tissue—Crohn's disease	6.42e-05	0.00596	CbGeAlD
Dexamethasone—CYP3A5—digestive system—Crohn's disease	6.4e-05	0.00593	CbGeAlD
Dexamethasone—CYP2B6—digestive system—Crohn's disease	6.36e-05	0.00589	CbGeAlD
Dexamethasone—NR3C1—digestive system—Crohn's disease	6.35e-05	0.00588	CbGeAlD
Dexamethasone—Contusion—Prednisone—Crohn's disease	6.34e-05	0.00192	CcSEcCtD
Dexamethasone—Amenorrhoea—Prednisone—Crohn's disease	6.3e-05	0.00191	CcSEcCtD
Dexamethasone—CYP2C9—digestive system—Crohn's disease	6.29e-05	0.00584	CbGeAlD
Dexamethasone—PGR—lymph node—Crohn's disease	6.28e-05	0.00582	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	6.26e-05	0.0019	CcSEcCtD
Dexamethasone—Arthropathy—Prednisone—Crohn's disease	6.08e-05	0.00185	CcSEcCtD
Dexamethasone—CYP2E1—lymphoid tissue—Crohn's disease	6.04e-05	0.0056	CbGeAlD
Dexamethasone—Decreased appetite—Mercaptopurine—Crohn's disease	5.98e-05	0.00181	CcSEcCtD
Dexamethasone—Weight increased—Mesalazine—Crohn's disease	5.97e-05	0.00181	CcSEcCtD
Dexamethasone—CYP2E1—digestive system—Crohn's disease	5.96e-05	0.00553	CbGeAlD
Dexamethasone—Weight decreased—Mesalazine—Crohn's disease	5.93e-05	0.0018	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	5.93e-05	0.0018	CcSEcCtD
Dexamethasone—Leukocytosis—Prednisone—Crohn's disease	5.89e-05	0.00179	CcSEcCtD
Dexamethasone—Ulcer—Prednisone—Crohn's disease	5.85e-05	0.00177	CcSEcCtD
Dexamethasone—Cataract—Prednisone—Crohn's disease	5.81e-05	0.00176	CcSEcCtD
Dexamethasone—Haemoglobin—Azathioprine—Crohn's disease	5.79e-05	0.00176	CcSEcCtD
Dexamethasone—Haemorrhage—Azathioprine—Crohn's disease	5.76e-05	0.00175	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Mesalazine—Crohn's disease	5.73e-05	0.00174	CcSEcCtD
Dexamethasone—Conjunctivitis—Mesalazine—Crohn's disease	5.69e-05	0.00173	CcSEcCtD
Dexamethasone—Vasculitis—Prednisone—Crohn's disease	5.67e-05	0.00172	CcSEcCtD
Dexamethasone—CYP19A1—lymph node—Crohn's disease	5.65e-05	0.00524	CbGeAlD
Dexamethasone—PTGS2—lymphoid tissue—Crohn's disease	5.56e-05	0.00516	CbGeAlD
Dexamethasone—Hiccups—Prednisone—Crohn's disease	5.53e-05	0.00168	CcSEcCtD
Dexamethasone—PTGS2—digestive system—Crohn's disease	5.49e-05	0.00509	CbGeAlD
Dexamethasone—Body temperature increased—Mercaptopurine—Crohn's disease	5.43e-05	0.00165	CcSEcCtD
Dexamethasone—ABCC2—lymph node—Crohn's disease	5.4e-05	0.005	CbGeAlD
Dexamethasone—CYP1B1—lymph node—Crohn's disease	5.28e-05	0.0049	CbGeAlD
Dexamethasone—Skin exfoliation—Prednisone—Crohn's disease	5.28e-05	0.0016	CcSEcCtD
Dexamethasone—Haemoglobin—Mesalazine—Crohn's disease	5.28e-05	0.0016	CcSEcCtD
Dexamethasone—Fluid retention—Prednisone—Crohn's disease	5.25e-05	0.00159	CcSEcCtD
Dexamethasone—Haemorrhage—Mesalazine—Crohn's disease	5.25e-05	0.00159	CcSEcCtD
Dexamethasone—Neuropathy—Prednisone—Crohn's disease	5.19e-05	0.00158	CcSEcCtD
Dexamethasone—Arrhythmia—Azathioprine—Crohn's disease	5.15e-05	0.00156	CcSEcCtD
Dexamethasone—Alopecia—Azathioprine—Crohn's disease	5.09e-05	0.00155	CcSEcCtD
Dexamethasone—Oesophagitis—Prednisone—Crohn's disease	5.06e-05	0.00153	CcSEcCtD
Dexamethasone—Ecchymosis—Prednisone—Crohn's disease	5e-05	0.00152	CcSEcCtD
Dexamethasone—Pulmonary oedema—Prednisone—Crohn's disease	4.92e-05	0.00149	CcSEcCtD
Dexamethasone—Eye disorder—Mesalazine—Crohn's disease	4.91e-05	0.00149	CcSEcCtD
Dexamethasone—CYP3A4—digestive system—Crohn's disease	4.8e-05	0.00445	CbGeAlD
Dexamethasone—Angiopathy—Mesalazine—Crohn's disease	4.76e-05	0.00145	CcSEcCtD
Dexamethasone—Euphoric mood—Prednisone—Crohn's disease	4.75e-05	0.00144	CcSEcCtD
Dexamethasone—CYP2D6—digestive system—Crohn's disease	4.72e-05	0.00438	CbGeAlD
Dexamethasone—Diarrhoea—Mercaptopurine—Crohn's disease	4.7e-05	0.00143	CcSEcCtD
Dexamethasone—Ill-defined disorder—Azathioprine—Crohn's disease	4.66e-05	0.00141	CcSEcCtD
Dexamethasone—Alopecia—Mesalazine—Crohn's disease	4.64e-05	0.00141	CcSEcCtD
Dexamethasone—Thrombophlebitis—Prednisone—Crohn's disease	4.64e-05	0.00141	CcSEcCtD
Dexamethasone—Diabetes mellitus—Prednisone—Crohn's disease	4.62e-05	0.0014	CcSEcCtD
Dexamethasone—Erythema—Mesalazine—Crohn's disease	4.57e-05	0.00139	CcSEcCtD
Dexamethasone—Malaise—Azathioprine—Crohn's disease	4.53e-05	0.00137	CcSEcCtD
Dexamethasone—ABCB1—epithelium—Crohn's disease	4.47e-05	0.00414	CbGeAlD
Dexamethasone—Cardiac failure congestive—Prednisone—Crohn's disease	4.43e-05	0.00134	CcSEcCtD
Dexamethasone—Vomiting—Mercaptopurine—Crohn's disease	4.37e-05	0.00133	CcSEcCtD
Dexamethasone—Injury—Prednisone—Crohn's disease	4.37e-05	0.00133	CcSEcCtD
Dexamethasone—Rash—Mercaptopurine—Crohn's disease	4.33e-05	0.00132	CcSEcCtD
Dexamethasone—Dermatitis—Mercaptopurine—Crohn's disease	4.33e-05	0.00131	CcSEcCtD
Dexamethasone—Increased appetite—Prednisone—Crohn's disease	4.27e-05	0.0013	CcSEcCtD
Dexamethasone—Myalgia—Azathioprine—Crohn's disease	4.27e-05	0.0013	CcSEcCtD
Dexamethasone—Ill-defined disorder—Mesalazine—Crohn's disease	4.24e-05	0.00129	CcSEcCtD
Dexamethasone—Discomfort—Azathioprine—Crohn's disease	4.22e-05	0.00128	CcSEcCtD
Dexamethasone—Angioedema—Mesalazine—Crohn's disease	4.18e-05	0.00127	CcSEcCtD
Dexamethasone—Malaise—Mesalazine—Crohn's disease	4.12e-05	0.00125	CcSEcCtD
Dexamethasone—Cardiac failure—Prednisone—Crohn's disease	4.11e-05	0.00125	CcSEcCtD
Dexamethasone—Vertigo—Mesalazine—Crohn's disease	4.11e-05	0.00125	CcSEcCtD
Dexamethasone—Syncope—Mesalazine—Crohn's disease	4.1e-05	0.00124	CcSEcCtD
Dexamethasone—Lethargy—Prednisone—Crohn's disease	4.1e-05	0.00124	CcSEcCtD
Dexamethasone—Nausea—Mercaptopurine—Crohn's disease	4.08e-05	0.00124	CcSEcCtD
Dexamethasone—Infection—Azathioprine—Crohn's disease	4.07e-05	0.00123	CcSEcCtD
Dexamethasone—Loss of consciousness—Mesalazine—Crohn's disease	4.02e-05	0.00122	CcSEcCtD
Dexamethasone—Osteoarthritis—Prednisone—Crohn's disease	4.02e-05	0.00122	CcSEcCtD
Dexamethasone—Thrombocytopenia—Azathioprine—Crohn's disease	4.01e-05	0.00122	CcSEcCtD
Dexamethasone—Affect lability—Prednisone—Crohn's disease	3.95e-05	0.0012	CcSEcCtD
Dexamethasone—Hypertension—Mesalazine—Crohn's disease	3.95e-05	0.0012	CcSEcCtD
Dexamethasone—ABCG2—lymph node—Crohn's disease	3.94e-05	0.00365	CbGeAlD
Dexamethasone—Psychotic disorder—Prednisone—Crohn's disease	3.92e-05	0.00119	CcSEcCtD
Dexamethasone—Myalgia—Mesalazine—Crohn's disease	3.89e-05	0.00118	CcSEcCtD
Dexamethasone—Anxiety—Mesalazine—Crohn's disease	3.88e-05	0.00118	CcSEcCtD
Dexamethasone—ABCB1—mammalian vulva—Crohn's disease	3.87e-05	0.00359	CbGeAlD
Dexamethasone—Discomfort—Mesalazine—Crohn's disease	3.84e-05	0.00117	CcSEcCtD
Dexamethasone—Irritability—Prednisone—Crohn's disease	3.83e-05	0.00116	CcSEcCtD
Dexamethasone—Hypotension—Azathioprine—Crohn's disease	3.83e-05	0.00116	CcSEcCtD
Dexamethasone—Cardiac arrest—Prednisone—Crohn's disease	3.82e-05	0.00116	CcSEcCtD
Dexamethasone—Mood swings—Prednisone—Crohn's disease	3.8e-05	0.00115	CcSEcCtD
Dexamethasone—CYP1A1—lymph node—Crohn's disease	3.74e-05	0.00346	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	3.73e-05	0.00113	CcSEcCtD
Dexamethasone—Anaphylactic shock—Mesalazine—Crohn's disease	3.73e-05	0.00113	CcSEcCtD
Dexamethasone—Oedema—Mesalazine—Crohn's disease	3.73e-05	0.00113	CcSEcCtD
Dexamethasone—Infection—Mesalazine—Crohn's disease	3.71e-05	0.00112	CcSEcCtD
Dexamethasone—Dry skin—Prednisone—Crohn's disease	3.68e-05	0.00112	CcSEcCtD
Dexamethasone—Shock—Mesalazine—Crohn's disease	3.67e-05	0.00111	CcSEcCtD
Dexamethasone—Nervous system disorder—Mesalazine—Crohn's disease	3.66e-05	0.00111	CcSEcCtD
Dexamethasone—Hypokalaemia—Prednisone—Crohn's disease	3.65e-05	0.00111	CcSEcCtD
Dexamethasone—Thrombocytopenia—Mesalazine—Crohn's disease	3.65e-05	0.00111	CcSEcCtD
Dexamethasone—Tachycardia—Mesalazine—Crohn's disease	3.64e-05	0.0011	CcSEcCtD
Dexamethasone—NR3C1—lymph node—Crohn's disease	3.62e-05	0.00336	CbGeAlD
Dexamethasone—Hyperhidrosis—Mesalazine—Crohn's disease	3.61e-05	0.00109	CcSEcCtD
Dexamethasone—Anorexia—Mesalazine—Crohn's disease	3.56e-05	0.00108	CcSEcCtD
Dexamethasone—Muscular weakness—Prednisone—Crohn's disease	3.54e-05	0.00107	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Azathioprine—Crohn's disease	3.54e-05	0.00107	CcSEcCtD
Dexamethasone—Hypotension—Mesalazine—Crohn's disease	3.49e-05	0.00106	CcSEcCtD
Dexamethasone—ABCB1—lymphoid tissue—Crohn's disease	3.44e-05	0.00319	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	3.4e-05	0.00103	CcSEcCtD
Dexamethasone—ABCB1—digestive system—Crohn's disease	3.4e-05	0.00315	CbGeAlD
Dexamethasone—Sweating increased—Prednisone—Crohn's disease	3.38e-05	0.00103	CcSEcCtD
Dexamethasone—Feeling abnormal—Azathioprine—Crohn's disease	3.37e-05	0.00102	CcSEcCtD
Dexamethasone—Insomnia—Mesalazine—Crohn's disease	3.37e-05	0.00102	CcSEcCtD
Dexamethasone—Paraesthesia—Mesalazine—Crohn's disease	3.35e-05	0.00102	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Azathioprine—Crohn's disease	3.35e-05	0.00102	CcSEcCtD
Dexamethasone—Dyspepsia—Mesalazine—Crohn's disease	3.28e-05	0.000996	CcSEcCtD
Dexamethasone—Decreased appetite—Mesalazine—Crohn's disease	3.24e-05	0.000984	CcSEcCtD
Dexamethasone—Body temperature increased—Azathioprine—Crohn's disease	3.24e-05	0.000982	CcSEcCtD
Dexamethasone—Abdominal pain—Azathioprine—Crohn's disease	3.24e-05	0.000982	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Mesalazine—Crohn's disease	3.22e-05	0.000977	CcSEcCtD
Dexamethasone—Fatigue—Mesalazine—Crohn's disease	3.22e-05	0.000976	CcSEcCtD
Dexamethasone—Pain—Mesalazine—Crohn's disease	3.19e-05	0.000968	CcSEcCtD
Dexamethasone—Weight increased—Prednisone—Crohn's disease	3.16e-05	0.000959	CcSEcCtD
Dexamethasone—Weight decreased—Prednisone—Crohn's disease	3.14e-05	0.000953	CcSEcCtD
Dexamethasone—PTGS2—lymph node—Crohn's disease	3.14e-05	0.00291	CbGeAlD
Dexamethasone—Hyperglycaemia—Prednisone—Crohn's disease	3.13e-05	0.00095	CcSEcCtD
Dexamethasone—Feeling abnormal—Mesalazine—Crohn's disease	3.07e-05	0.000933	CcSEcCtD
Dexamethasone—Acute coronary syndrome—Prednisone—Crohn's disease	3.05e-05	0.000926	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Mesalazine—Crohn's disease	3.05e-05	0.000926	CcSEcCtD
Dexamethasone—Myocardial infarction—Prednisone—Crohn's disease	3.03e-05	0.000921	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Prednisone—Crohn's disease	3.03e-05	0.000921	CcSEcCtD
Dexamethasone—Urticaria—Mesalazine—Crohn's disease	2.96e-05	0.000899	CcSEcCtD
Dexamethasone—Body temperature increased—Mesalazine—Crohn's disease	2.95e-05	0.000895	CcSEcCtD
Dexamethasone—Abdominal pain—Mesalazine—Crohn's disease	2.95e-05	0.000895	CcSEcCtD
Dexamethasone—Bradycardia—Prednisone—Crohn's disease	2.83e-05	0.000858	CcSEcCtD
Dexamethasone—Diarrhoea—Azathioprine—Crohn's disease	2.8e-05	0.00085	CcSEcCtD
Dexamethasone—Haemoglobin—Prednisone—Crohn's disease	2.79e-05	0.000847	CcSEcCtD
Dexamethasone—Haemorrhage—Prednisone—Crohn's disease	2.78e-05	0.000843	CcSEcCtD
Dexamethasone—Hallucination—Prednisone—Crohn's disease	2.76e-05	0.000839	CcSEcCtD
Dexamethasone—Dizziness—Azathioprine—Crohn's disease	2.71e-05	0.000822	CcSEcCtD
Dexamethasone—Asthenia—Mesalazine—Crohn's disease	2.68e-05	0.000812	CcSEcCtD
Dexamethasone—Pruritus—Mesalazine—Crohn's disease	2.64e-05	0.000801	CcSEcCtD
Dexamethasone—Vomiting—Azathioprine—Crohn's disease	2.6e-05	0.00079	CcSEcCtD
Dexamethasone—Eye disorder—Prednisone—Crohn's disease	2.6e-05	0.000788	CcSEcCtD
Dexamethasone—Rash—Azathioprine—Crohn's disease	2.58e-05	0.000784	CcSEcCtD
Dexamethasone—Dermatitis—Azathioprine—Crohn's disease	2.58e-05	0.000783	CcSEcCtD
Dexamethasone—Headache—Azathioprine—Crohn's disease	2.57e-05	0.000779	CcSEcCtD
Dexamethasone—Diarrhoea—Mesalazine—Crohn's disease	2.55e-05	0.000775	CcSEcCtD
Dexamethasone—Angiopathy—Prednisone—Crohn's disease	2.52e-05	0.000765	CcSEcCtD
Dexamethasone—Arrhythmia—Prednisone—Crohn's disease	2.48e-05	0.000753	CcSEcCtD
Dexamethasone—Dizziness—Mesalazine—Crohn's disease	2.47e-05	0.000749	CcSEcCtD
Dexamethasone—Alopecia—Prednisone—Crohn's disease	2.45e-05	0.000745	CcSEcCtD
Dexamethasone—Nausea—Azathioprine—Crohn's disease	2.43e-05	0.000738	CcSEcCtD
Dexamethasone—Erythema—Prednisone—Crohn's disease	2.42e-05	0.000734	CcSEcCtD
Dexamethasone—Vomiting—Mesalazine—Crohn's disease	2.37e-05	0.00072	CcSEcCtD
Dexamethasone—Rash—Mesalazine—Crohn's disease	2.35e-05	0.000714	CcSEcCtD
Dexamethasone—Dermatitis—Mesalazine—Crohn's disease	2.35e-05	0.000713	CcSEcCtD
Dexamethasone—Headache—Mesalazine—Crohn's disease	2.34e-05	0.000709	CcSEcCtD
Dexamethasone—Ill-defined disorder—Prednisone—Crohn's disease	2.24e-05	0.000681	CcSEcCtD
Dexamethasone—Nausea—Mesalazine—Crohn's disease	2.22e-05	0.000672	CcSEcCtD
Dexamethasone—Angioedema—Prednisone—Crohn's disease	2.21e-05	0.000671	CcSEcCtD
Dexamethasone—Malaise—Prednisone—Crohn's disease	2.18e-05	0.000662	CcSEcCtD
Dexamethasone—Vertigo—Prednisone—Crohn's disease	2.17e-05	0.000659	CcSEcCtD
Dexamethasone—Syncope—Prednisone—Crohn's disease	2.17e-05	0.000658	CcSEcCtD
Dexamethasone—Loss of consciousness—Prednisone—Crohn's disease	2.13e-05	0.000645	CcSEcCtD
Dexamethasone—Convulsion—Prednisone—Crohn's disease	2.1e-05	0.000636	CcSEcCtD
Dexamethasone—Hypertension—Prednisone—Crohn's disease	2.09e-05	0.000634	CcSEcCtD
Dexamethasone—Myalgia—Prednisone—Crohn's disease	2.06e-05	0.000625	CcSEcCtD
Dexamethasone—Anxiety—Prednisone—Crohn's disease	2.05e-05	0.000623	CcSEcCtD
Dexamethasone—Discomfort—Prednisone—Crohn's disease	2.03e-05	0.000617	CcSEcCtD
Dexamethasone—Oedema—Prednisone—Crohn's disease	1.97e-05	0.000599	CcSEcCtD
Dexamethasone—Anaphylactic shock—Prednisone—Crohn's disease	1.97e-05	0.000599	CcSEcCtD
Dexamethasone—Infection—Prednisone—Crohn's disease	1.96e-05	0.000595	CcSEcCtD
Dexamethasone—Shock—Prednisone—Crohn's disease	1.94e-05	0.000589	CcSEcCtD
Dexamethasone—ABCB1—lymph node—Crohn's disease	1.94e-05	0.0018	CbGeAlD
Dexamethasone—Nervous system disorder—Prednisone—Crohn's disease	1.94e-05	0.000587	CcSEcCtD
Dexamethasone—Tachycardia—Prednisone—Crohn's disease	1.93e-05	0.000585	CcSEcCtD
Dexamethasone—Hyperhidrosis—Prednisone—Crohn's disease	1.91e-05	0.000579	CcSEcCtD
Dexamethasone—Anorexia—Prednisone—Crohn's disease	1.88e-05	0.000571	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Prednisone—Crohn's disease	1.8e-05	0.000546	CcSEcCtD
Dexamethasone—Insomnia—Prednisone—Crohn's disease	1.79e-05	0.000542	CcSEcCtD
Dexamethasone—Paraesthesia—Prednisone—Crohn's disease	1.77e-05	0.000538	CcSEcCtD
Dexamethasone—Dyspepsia—Prednisone—Crohn's disease	1.74e-05	0.000527	CcSEcCtD
Dexamethasone—Decreased appetite—Prednisone—Crohn's disease	1.72e-05	0.000521	CcSEcCtD
Dexamethasone—Fatigue—Prednisone—Crohn's disease	1.7e-05	0.000516	CcSEcCtD
Dexamethasone—Feeling abnormal—Prednisone—Crohn's disease	1.63e-05	0.000494	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Prednisone—Crohn's disease	1.61e-05	0.00049	CcSEcCtD
Dexamethasone—Urticaria—Prednisone—Crohn's disease	1.57e-05	0.000476	CcSEcCtD
Dexamethasone—Body temperature increased—Prednisone—Crohn's disease	1.56e-05	0.000473	CcSEcCtD
Dexamethasone—Abdominal pain—Prednisone—Crohn's disease	1.56e-05	0.000473	CcSEcCtD
Dexamethasone—Asthenia—Prednisone—Crohn's disease	1.42e-05	0.00043	CcSEcCtD
Dexamethasone—Pruritus—Prednisone—Crohn's disease	1.4e-05	0.000424	CcSEcCtD
Dexamethasone—Diarrhoea—Prednisone—Crohn's disease	1.35e-05	0.00041	CcSEcCtD
Dexamethasone—Dizziness—Prednisone—Crohn's disease	1.31e-05	0.000396	CcSEcCtD
Dexamethasone—Vomiting—Prednisone—Crohn's disease	1.25e-05	0.000381	CcSEcCtD
Dexamethasone—Rash—Prednisone—Crohn's disease	1.24e-05	0.000378	CcSEcCtD
Dexamethasone—Dermatitis—Prednisone—Crohn's disease	1.24e-05	0.000377	CcSEcCtD
Dexamethasone—Headache—Prednisone—Crohn's disease	1.24e-05	0.000375	CcSEcCtD
Dexamethasone—Nausea—Prednisone—Crohn's disease	1.17e-05	0.000356	CcSEcCtD
Dexamethasone—PGR—Signaling by ERBB4—IL6—Crohn's disease	5.92e-06	0.000348	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—HSPA1B—Crohn's disease	5.9e-06	0.000347	CbGpPWpGaD
Dexamethasone—SLCO1A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.87e-06	0.000345	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.84e-06	0.000343	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IL3—Crohn's disease	5.81e-06	0.000342	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—FADS1—Crohn's disease	5.81e-06	0.000342	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PLA2G4F—Crohn's disease	5.8e-06	0.000341	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	5.75e-06	0.000338	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—IL1B—Crohn's disease	5.73e-06	0.000337	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	5.69e-06	0.000335	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	5.69e-06	0.000335	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	5.66e-06	0.000333	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—MTMR3—Crohn's disease	5.63e-06	0.000331	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—RASGRP1—Crohn's disease	5.62e-06	0.000331	CbGpPWpGaD
Dexamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—Crohn's disease	5.61e-06	0.00033	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.59e-06	0.000329	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—STAT3—Crohn's disease	5.55e-06	0.000327	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	5.53e-06	0.000325	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.47e-06	0.000322	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—GPX4—Crohn's disease	5.44e-06	0.00032	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	5.43e-06	0.000319	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—MTMR3—Crohn's disease	5.42e-06	0.000319	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.35e-06	0.000315	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—IL1B—Crohn's disease	5.3e-06	0.000312	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PLA2G4F—Crohn's disease	5.27e-06	0.00031	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—GCKR—Crohn's disease	5.26e-06	0.000309	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—UBE2D1—Crohn's disease	5.17e-06	0.000304	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—JAK2—Crohn's disease	5.1e-06	0.0003	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—SOCS1—Crohn's disease	5.09e-06	0.0003	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—DNMT3A—Crohn's disease	5.04e-06	0.000297	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.01e-06	0.000295	CbGpPWpGaD
Dexamethasone—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	4.98e-06	0.000293	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—MTMR3—Crohn's disease	4.93e-06	0.00029	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—MTMR3—Crohn's disease	4.89e-06	0.000287	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—TYK2—Crohn's disease	4.86e-06	0.000286	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—FADS1—Crohn's disease	4.85e-06	0.000285	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—TNF—Crohn's disease	4.81e-06	0.000283	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.78e-06	0.000281	CbGpPWpGaD
Dexamethasone—NOS2—Disease—SMAD3—Crohn's disease	4.74e-06	0.000279	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.68e-06	0.000275	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—CXCL8—Crohn's disease	4.66e-06	0.000274	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—JAK2—Crohn's disease	4.63e-06	0.000273	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—RSPO3—Crohn's disease	4.62e-06	0.000272	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—GPX4—Crohn's disease	4.54e-06	0.000267	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—MTMR3—Crohn's disease	4.48e-06	0.000263	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.47e-06	0.000263	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—SMAD3—Crohn's disease	4.44e-06	0.000261	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PLA2G4F—Crohn's disease	4.42e-06	0.00026	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—SMAD3—Crohn's disease	4.4e-06	0.000259	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—GCKR—Crohn's disease	4.39e-06	0.000258	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—FADS1—Crohn's disease	4.38e-06	0.000258	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SEL1L—Crohn's disease	4.38e-06	0.000257	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.36e-06	0.000256	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.28e-06	0.000252	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PLA2G4F—Crohn's disease	4.25e-06	0.00025	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCR6—Crohn's disease	4.24e-06	0.000249	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.23e-06	0.000249	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—CXCL8—Crohn's disease	4.23e-06	0.000249	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—FADS1—Crohn's disease	4.22e-06	0.000248	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	4.16e-06	0.000245	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—Crohn's disease	4.15e-06	0.000244	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	4.15e-06	0.000244	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—GPX4—Crohn's disease	4.11e-06	0.000241	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.09e-06	0.000241	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.08e-06	0.00024	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IL2RA—Crohn's disease	4.07e-06	0.00024	CbGpPWpGaD
Dexamethasone—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	4.02e-06	0.000236	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.01e-06	0.000236	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—GCKR—Crohn's disease	3.97e-06	0.000233	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—GPX4—Crohn's disease	3.95e-06	0.000233	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	3.94e-06	0.000232	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PLA2G4F—Crohn's disease	3.93e-06	0.000231	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—LTF—Crohn's disease	3.92e-06	0.000231	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—IL6—Crohn's disease	3.88e-06	0.000228	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—TNF—Crohn's disease	3.85e-06	0.000226	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—FADS1—Crohn's disease	3.84e-06	0.000226	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RBX1—Crohn's disease	3.83e-06	0.000225	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—GCKR—Crohn's disease	3.82e-06	0.000225	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—FADS1—Crohn's disease	3.81e-06	0.000224	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—MTMR3—Crohn's disease	3.76e-06	0.000221	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.76e-06	0.000221	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.74e-06	0.00022	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PTGER4—Crohn's disease	3.73e-06	0.000219	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.7e-06	0.000218	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—SMAD3—Crohn's disease	3.7e-06	0.000218	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—MTMR3—Crohn's disease	3.61e-06	0.000213	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PLA2G4F—Crohn's disease	3.6e-06	0.000212	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—GPX4—Crohn's disease	3.6e-06	0.000212	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—GPX4—Crohn's disease	3.57e-06	0.00021	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.54e-06	0.000209	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—MTMR3—Crohn's disease	3.54e-06	0.000208	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—MTMR3—Crohn's disease	3.53e-06	0.000208	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—FADS1—Crohn's disease	3.49e-06	0.000205	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—GCKR—Crohn's disease	3.47e-06	0.000204	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—ALB—Crohn's disease	3.46e-06	0.000203	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—GCKR—Crohn's disease	3.44e-06	0.000203	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—HSPA1B—Crohn's disease	3.41e-06	0.0002	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—UBE2D1—Crohn's disease	3.36e-06	0.000198	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—Crohn's disease	3.35e-06	0.000197	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—MTMR3—Crohn's disease	3.34e-06	0.000196	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.29e-06	0.000193	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—GPX4—Crohn's disease	3.27e-06	0.000192	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RIPK2—Crohn's disease	3.26e-06	0.000192	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	3.21e-06	0.000189	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL3—Crohn's disease	3.18e-06	0.000187	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	3.18e-06	0.000187	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—GCKR—Crohn's disease	3.16e-06	0.000186	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—GCKR—Crohn's disease	3.16e-06	0.000186	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.14e-06	0.000184	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PLA2G4F—Crohn's disease	3.14e-06	0.000184	CbGpPWpGaD
Dexamethasone—NOS2—Disease—TYK2—Crohn's disease	3.09e-06	0.000182	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RASGRP1—Crohn's disease	3.07e-06	0.000181	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—MTMR3—Crohn's disease	3.06e-06	0.00018	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—PTGS2—Crohn's disease	3.02e-06	0.000178	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—UBE2D1—Crohn's disease	2.99e-06	0.000176	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.98e-06	0.000175	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	2.95e-06	0.000174	CbGpPWpGaD
Dexamethasone—NOS2—Disease—JAK2—Crohn's disease	2.95e-06	0.000173	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—FADS1—Crohn's disease	2.93e-06	0.000172	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	2.93e-06	0.000172	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TYK2—Crohn's disease	2.87e-06	0.000169	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.83e-06	0.000167	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—FADS1—Crohn's disease	2.82e-06	0.000166	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.81e-06	0.000165	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SLC11A1—Crohn's disease	2.8e-06	0.000165	CbGpPWpGaD
Dexamethasone—NOS2—Disease—CD4—Crohn's disease	2.79e-06	0.000164	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SOCS1—Crohn's disease	2.78e-06	0.000164	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PTGS2—Crohn's disease	2.77e-06	0.000163	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—FADS1—Crohn's disease	2.76e-06	0.000162	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—FADS1—Crohn's disease	2.75e-06	0.000162	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GPX4—Crohn's disease	2.74e-06	0.000161	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.74e-06	0.000161	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—JAK2—Crohn's disease	2.74e-06	0.000161	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—MTMR3—Crohn's disease	2.73e-06	0.000161	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.73e-06	0.000161	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—ALB—Crohn's disease	2.72e-06	0.00016	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.71e-06	0.00016	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.68e-06	0.000158	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—MTMR3—Crohn's disease	2.67e-06	0.000157	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GCKR—Crohn's disease	2.65e-06	0.000156	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GPX4—Crohn's disease	2.64e-06	0.000155	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—FADS1—Crohn's disease	2.6e-06	0.000153	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GPX4—Crohn's disease	2.58e-06	0.000152	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GPX4—Crohn's disease	2.58e-06	0.000152	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GCKR—Crohn's disease	2.55e-06	0.00015	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—MTMR3—Crohn's disease	2.51e-06	0.000148	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CXCL8—Crohn's disease	2.5e-06	0.000147	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GCKR—Crohn's disease	2.49e-06	0.000147	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—MTMR3—Crohn's disease	2.49e-06	0.000146	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GCKR—Crohn's disease	2.49e-06	0.000146	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.48e-06	0.000146	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GPX4—Crohn's disease	2.43e-06	0.000143	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—SMAD3—Crohn's disease	2.4e-06	0.000141	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—RBX1—Crohn's disease	2.4e-06	0.000141	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HSPA1B—Crohn's disease	2.4e-06	0.000141	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.39e-06	0.00014	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—FADS1—Crohn's disease	2.38e-06	0.00014	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PTGS2—Crohn's disease	2.38e-06	0.00014	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—IL6—Crohn's disease	2.38e-06	0.00014	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.36e-06	0.000139	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GCKR—Crohn's disease	2.35e-06	0.000138	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GPX4—Crohn's disease	2.23e-06	0.000131	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL2RA—Crohn's disease	2.23e-06	0.000131	CbGpPWpGaD
Dexamethasone—NOS2—Disease—STAT3—Crohn's disease	2.16e-06	0.000127	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GCKR—Crohn's disease	2.16e-06	0.000127	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—SMAD3—Crohn's disease	2.14e-06	0.000126	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—FADS1—Crohn's disease	2.13e-06	0.000125	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—UBE2D1—Crohn's disease	2.1e-06	0.000124	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—ALB—Crohn's disease	2.08e-06	0.000123	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—FADS1—Crohn's disease	2.08e-06	0.000122	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—STAT3—Crohn's disease	2.01e-06	0.000118	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GPX4—Crohn's disease	1.99e-06	0.000117	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—FADS1—Crohn's disease	1.96e-06	0.000115	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GPX4—Crohn's disease	1.94e-06	0.000114	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—FADS1—Crohn's disease	1.94e-06	0.000114	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.93e-06	0.000114	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GCKR—Crohn's disease	1.92e-06	0.000113	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—ALB—Crohn's disease	1.91e-06	0.000112	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.9e-06	0.000112	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.89e-06	0.000111	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—ALB—Crohn's disease	1.89e-06	0.000111	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GCKR—Crohn's disease	1.88e-06	0.00011	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GPX4—Crohn's disease	1.83e-06	0.000108	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PTGS2—Crohn's disease	1.82e-06	0.000107	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GPX4—Crohn's disease	1.82e-06	0.000107	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GCKR—Crohn's disease	1.77e-06	0.000104	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GCKR—Crohn's disease	1.75e-06	0.000103	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.68e-06	9.88e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—ALB—Crohn's disease	1.67e-06	9.84e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PTGS2—Crohn's disease	1.67e-06	9.8e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PTGS2—Crohn's disease	1.65e-06	9.7e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.64e-06	9.66e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TYK2—Crohn's disease	1.57e-06	9.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.54e-06	9.06e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—IL6—Crohn's disease	1.51e-06	8.89e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SMAD3—Crohn's disease	1.5e-06	8.85e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—JAK2—Crohn's disease	1.5e-06	8.8e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.47e-06	8.65e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTGS2—Crohn's disease	1.46e-06	8.61e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—IL6—Crohn's disease	1.4e-06	8.25e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ALB—Crohn's disease	1.4e-06	8.21e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.38e-06	8.09e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CXCL8—Crohn's disease	1.37e-06	8.03e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.35e-06	7.93e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—FADS1—Crohn's disease	1.28e-06	7.53e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.28e-06	7.51e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ALB—Crohn's disease	1.26e-06	7.42e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.25e-06	7.38e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTGS2—Crohn's disease	1.22e-06	7.19e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ALB—Crohn's disease	1.22e-06	7.15e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.2e-06	7.08e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GPX4—Crohn's disease	1.2e-06	7.05e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GCKR—Crohn's disease	1.16e-06	6.81e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ALB—Crohn's disease	1.11e-06	6.5e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—Crohn's disease	1.1e-06	6.49e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—STAT3—Crohn's disease	1.1e-06	6.46e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.1e-06	6.45e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ALB—Crohn's disease	1.1e-06	6.45e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—Crohn's disease	1.06e-06	6.25e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ALB—Crohn's disease	1e-06	5.91e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TYK2—Crohn's disease	9.81e-07	5.77e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—Crohn's disease	9.67e-07	5.69e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—Crohn's disease	9.59e-07	5.64e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—JAK2—Crohn's disease	9.36e-07	5.51e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD4—Crohn's disease	8.87e-07	5.22e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—Crohn's disease	8.79e-07	5.17e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ALB—Crohn's disease	8.43e-07	4.96e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ALB—Crohn's disease	8.1e-07	4.77e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ALB—Crohn's disease	7.94e-07	4.67e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ALB—Crohn's disease	7.92e-07	4.66e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6—Crohn's disease	7.67e-07	4.51e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ALB—Crohn's disease	7.48e-07	4.4e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—Crohn's disease	7.09e-07	4.17e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—Crohn's disease	6.94e-07	4.08e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—Crohn's disease	6.93e-07	4.08e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—Crohn's disease	6.87e-07	4.04e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ALB—Crohn's disease	6.86e-07	4.04e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—Crohn's disease	6.55e-07	3.85e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ALB—Crohn's disease	6.12e-07	3.6e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—Crohn's disease	6e-07	3.53e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ALB—Crohn's disease	5.98e-07	3.52e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ALB—Crohn's disease	5.63e-07	3.31e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ALB—Crohn's disease	5.58e-07	3.28e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—Crohn's disease	5.36e-07	3.15e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—Crohn's disease	5.23e-07	3.08e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—Crohn's disease	4.93e-07	2.9e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—Crohn's disease	4.89e-07	2.87e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6—Crohn's disease	4.8e-07	2.82e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALB—Crohn's disease	3.68e-07	2.17e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.22e-07	1.9e-05	CbGpPWpGaD
